Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.22 - $60.16 $7 Million - $8.22 Million
136,600 New
136,600 $7.21 Million
Q1 2022

May 17, 2022

BUY
$29.74 - $46.0 $954,654 - $1.48 Million
32,100 Added 95.54%
65,700 $2.42 Million
Q4 2021

Feb 15, 2022

BUY
$34.35 - $46.38 $391,590 - $528,732
11,400 Added 51.35%
33,600 $1.53 Million
Q3 2021

Nov 16, 2021

SELL
$18.54 - $35.74 $367,092 - $707,652
-19,800 Reduced 47.14%
22,200 $793,000
Q4 2020

Feb 17, 2021

BUY
$15.26 - $28.61 $386,078 - $723,833
25,300 Added 151.5%
42,000 $873,000
Q3 2020

Nov 17, 2020

BUY
$20.58 - $28.96 $123,479 - $173,760
6,000 Added 56.07%
16,700 $362,000
Q2 2020

Aug 17, 2020

BUY
$11.15 - $24.64 $119,305 - $263,648
10,700 New
10,700 $252,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $3.97B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.